反応式
[Cl:1][C:2]1[N:3]=[C:4]2[NH:12][C@H:11]([C:13]([F:16])([F:15])[F:14])[CH2:10][CH2:9][N:5]2[C:6](=[O:8])[CH:7]=1.Br.Br[CH2:19][C:20]([C:22]1[CH:31]=[N:30][C:29]2[NH:28][CH2:27][CH2:26][O:25][C:24]=2[CH:23]=1)=[O:21]>>[Cl:1][C:2]1[N:3]=[C:4]2[N:12]([CH2:19][C:20]([C:22]3[CH:31]=[N:30][C:29]4[NH:28][CH2:27][CH2:26][O:25][C:24]=4[CH:23]=3)=[O:21])[C@H:11]([C:13]([F:14])([F:15])[F:16])[CH2:10][CH2:9][N:5]2[C:6](=[O:8])[CH:7]=1参加物
3
反応物 2
生成物 1
実験手順
200 mg (0.79 mmol) of (8S)-2-chloro-8-trifluoromethyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one and 319.86 mg (0.95 mmol) of 2-bromo-1-(3,4-dihydro-2H-pyrido[3,2-b][1,4]oxazin-7-yl)ethanone hydrobromide were used in the reaction. After purification by chromatography on silica gel (eluent: 90/10 DCM/MeOH), 110 mg of (8S)-2-chloro-9-[2-(3,4-dihydro-2H-pyrido[3,2-b][1,4]oxazin-7-yl)-2-oxoethyl]-8-trifluoromethyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one are obtained, the characteristics of which are as follows:
後処理
- customAfter purification by chromatography on silica gel (eluent: 90/10 DCM/MeOH), 110 mg of (8S)-2-chloro-9-[2-(3,4-dihydro-2H-pyrido[3,2-b][1,4]oxazin-7-yl)-2-oxoethyl]-8-trifluoromethyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one
- customare obtained
出典と根拠
- ORDレコード
- ord-1ba9004e35e646dbbac2274a7a20b390
- 出典データセット
- uspto-grants-2016_04
- 特許番号
- US09321790B2
関連ノート
読み込み中…